Friday ،May 24, 2024، 20:53

Soha Pharmaceutical Company starts negotiations with reputable companies aims to collaborate in the production of new products, diversify its product portfolio

Soha Pharmaceutical Company starts negotiations with reputable companies aims to collaborate in the production of new products, diversify its product portfolio
One of the key programs of Soha Pharmaceutical Company in the year of ‘Surge in Production through People’s Participation’ includes developing the product portfolio and producing new products with high-efficacy by deploying state-of-the-art technology.

According to the report issued by Public Relations and International Affairs unit of the Medical Procurement Organization, Soha Pharmaceutical Company plans to enhance its production and sales growth compared to previous years in both domestic and international markets. It also seeks to gain a larger market share in existing and new therapeutic groups in line with this year's slogan.

 

Upgrading and improving production standards and GMP through the collaboration with relevant experts, developing strategic partnerships with academic-scientific centers and knowledge-based companies of the private sector, empowering and enhancing human capital through training, employing specialized and elite individuals, and collaborative and contractual production with knowledge-based companies without factories are among the major actions of the company in the new year to increase product portfolio diversity.

 

It is worth mentioning that improving productivity in all aspects, especially production, involving all personnel in line with realizing this year's slogan, is one of the company's key plans.

Apr 14, 2024 14:02

Comments

Sender name is required
Email is required
Characters left: 500
Comment is required